Oncology status update: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Line 1,077: Line 1,077:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Small intestine cancer
| style="padding: 5px 5px; background: #F5F5F5;" |Small intestine cancer
{| class="wikitable"
|
|-
|
|-
|
|-
|
|-
|
|-
|
|-
|
|-
|
|-
|
|-
|
|-
|Cervical polyp (SP)
|-
|Endodermal sinus tumor
|-
|Endometrial cancer
|-
|Endometrial hyperplasia
|-
|Endometrial intraepithelial neoplasia (SP)
|-
|Gestational trophoblastic neoplasia
|-
|Ovarian cancer (LP)
|-
|Epithelial ovarian tumors
|-
|Ovarian germ cell tumor
|-
|Sexcord/ stromal ovarian tumor
|-
|Krukenberg tumor (SP)
|-
|Meigs syndrome (SP)
|-
|Ovarian Sarcoma
|}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,214: Line 1,165:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Cervical polyp (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,222: Line 1,173:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Endodermal sinus tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,231: Line 1,182:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Endometrial cancer
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,239: Line 1,190:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Endometrial hyperplasia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,248: Line 1,199:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Endometrial intraepithelial neoplasia (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,256: Line 1,207:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Gestational trophoblastic neoplasia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,265: Line 1,216:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Ovarian cancer (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,273: Line 1,224:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Epithelial ovarian tumors
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,282: Line 1,233:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Ovarian germ cell tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,290: Line 1,241:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sexcord/ stromal ovarian tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,299: Line 1,250:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Krukenberg tumor (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,307: Line 1,258:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Meigs syndrome (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,316: Line 1,267:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Ovarian Sarcoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |

Revision as of 05:53, 3 July 2020

System leader: Farima Kahe, M.D.

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Oncology

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Oncology

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Oncology Acute lymphoblastic leukemia
Acute myeloid leukemia
Acute promyelocytic leukemia
Adult T-cell leukemia
Anaplastic large cell lymphoma
Burkitt's lymphoma
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic neutrophilic leukemia
Diffuse large B cell lymphoma
Follicular lymphoma
Hairy cell leukemia
Hodgkin's lymphoma
Leukemia (LP)
Leukocytosis (SP)
Hemophilia
Lymphadenopathy
Lymphangioma
Lymphangiomyomatosis (SP)
Lymphangiosarcoma (SP)
Lymphoma (LP)
Lymphomatoid granulomatosis
Mast cell leukemia
Mast cell tumor
Multiple myeloma
Myelodysplastic syndrome
Myelofibrosis
Nodal marginal zone lymphoma
Non-Hodgkin lymphoma (LP)
Polycythemia vera
Primary effusion lymphoma
Primary mediastinal large B-cell lymphoma (SP)
Prolymphocytic leukemia (LP)
T cell prolymphocytic leukemia (SP)
B cell prolymphocytic leukemia (SP)
Splenic marginal zone lymphoma
Enteropathy-associated T-cell lymphoma
T-cell lymphoma (LP)
Waldenström's macroglobulinemia
Hepatosplenic T cell lymphoma
Hypopharyngeal cancer
Laryngeal cancer
Oral cancer
Salivary gland tumor (LP)
Tongue cancer
Pleomorphic adenoma
Mucoepidermoid carcinoma
Nasopharyngeal angiofibroma (SP)
Nasopharyngeal carcinoma
Warthin's tumor
Appendix cancer
Blue rubber bleb nevus syndrome
Carcinoid syndrome
Cholangiocarcinoma
Colorectal cancer
Desmoplastic small round cell tumor (SP)
Esophageal cancer
Familial adenomatous polyposis
Fibrolamellar hepatocellular carcinoma (SP)
Gallbladder cancer
Gastrointestinal stromal tumor
Hepatoblastoma
Hepatocellular adenoma
Hepatocellular carcinoma
Hereditary nonpolyposis colorectal cancer
Liver mass
MALT lymphoma
Mantle cell lymphoma
Pancreatic cancer
Pancreatic islet cell carcinoma
Peutz-Jeghers syndrome
Pseudomyxoma peritonei (SP)
Small intestine cancer
Stomach cancer
Villous adenoma (SP)
VIPoma
Zollinger-Ellison syndrome
Peritoneal carcinomatosis (SP)
Breast cancer
Breast lumps
Cervical cancer
Cervical intraepithelial neoplasia (SP)
Cervical polyp (SP)
Endodermal sinus tumor
Endometrial cancer
Endometrial hyperplasia
Endometrial intraepithelial neoplasia (SP)
Gestational trophoblastic neoplasia
Ovarian cancer (LP)
Epithelial ovarian tumors
Ovarian germ cell tumor
Sexcord/ stromal ovarian tumor
Krukenberg tumor (SP)
Meigs syndrome (SP)
Ovarian Sarcoma
Retrieved from "https://www.wikidoc.org/index.php?title=Oncology_status_update&oldid=1621004"